Stocksigma LogoStocksigma Logo

Natco Pharma Board to Consider Q2 Results and Second Interim Dividend

Natco Pharma Limited's Board of Directors is scheduled to meet on 13th Nov'26 to consider and approve the unaudited financial results for the quarter and

Natco Pharma Board to Consider Q2 Results and Second Interim Dividend

Natco Pharma Ltd 路 Intimation 路 13 Nov 2026, 5:30 am

Natco Pharma Board to Consider Q2 Results and Second Interim Dividend Natco Pharma Limited's Board of Directors is scheduled to meet on 13th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the board will evaluate the declaration of a second interim dividend for FY27. In compliance with insider trading regulations, the trading window for dealing in company securities remains closed for designated persons and insiders from 30th Oct'26 through 15th Nov'26, re-opening on 16th Nov'26.

Original exchange filing (PDF)

More announcements from Natco Pharma Ltd

All Natco Pharma Ltd announcements